High-speed microscopy reveals electrical activity across the brain
On Aug. 14, 2026, a team of engineers at Massachusetts Institute of Technology (MIT) announced they have invented…
-
-
Artificial Intelligence | Biotechnology | Genomics | Infectious Disease | Medical Device | Nanotechnology | Neurology | NIH | Non-Profit Research | Therapeutics
Stanford Medicine researchers awarded $20 million for AI-guided research facilities
On Aug. 5, 2026, the National Science Foundation (NSF) has awarded a $20 million grant to a collaboration…
-
U.S. FDA Approves Takeda’s ORZEYFUL™ , the First and Only Medicine to Treat Narcolepsy
On Aug. 5, 2026, Takeda announced that the U.S. Food and Drug Administration (FDA) had approved ORZEYFUL™ (oveporexton),…
-
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness
On Aug. 3, 2026, UCLA researchers announced they have grown brain cells from dozens of genetically distinct donors…
-
Biotechnology | Imaging | Medical Device | Neurology | Non-Profit Research | Oncology | Therapeutics
UVA Radiology Professors Develop New Focused Ultrasound Approach for Brain Tumors
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
-
Blood Proteins May Predict When Genetically At-Risk People Develop ALS
On Jul. 27, 2026, an international research team led by University of Miami Miller School of Medicine scientists…
-
Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for Treatment of ADHD
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
-
Feinstein Institutes technology that restores movement and sensation after paralysis Published in Nature Medicine
On Jul. 16, 2026, the Feinstein Institutes for Medical Research announced findings featured in Nature Medicine demonstrating that…
-
Lilly to acquire AtaiBeckley for $3.8 billion advancing therapies for treatment-resistant depression
On Jul. 16, 2026, Eli Lilly and AtaiBeckley, a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health…
-
U.S. Army receive new medical equipment to detect TBIs faster
On Jul. 16, 2026, U.S. Army medical leaders in Europe announced they were fielding a new handheld diagnostic…
-
FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer’s Disease
On Jul. 13, 2026, Eisai Co. and Biogen announced that the U.S. Food and Drug Administration (FDA) has…
-
Biotechnology | Disease | Neurology | Oncology | Rare Disease | Stem Cell
New CRISPR Method Makes It Possible to Control Protein Production in Cells
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
-
Immunotherapy shows promise in treating deadly brain tumours
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
-
Alzheimer’s proteins in blood linked to midlife cognition
On Jul. 1, 2026, the National Institutes of Health (NIH) reported that a study found that people in…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic debuts AI-driven pharma R&D tool, Claude Science
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
-
EU Approves first tumour agnostic HER2-directed therapy for Breast Cancer
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
-
Dementia Will Cost the U.S. $818 Billion in 2026, USC-Led Study Finds
On Jun. 24, 2026, A University of Southern California (USC)-led study finds Alzheimer’s disease and related dementias will…
-
An experimental molecule “reprograms” the brain’s defenses against Alzheimer’s disease
On Jun. 17, 2026, a team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences…
-
First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
-
Roche announces global collaboration with Nurix Therapeutics worth up to $2.3 billion
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
-
New study explores potential cross-species spread of chronic wasting disease
On May 28, 2026, In a newly published study in Science Advances, researchers from the University of Calgary and collaborators…
-
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
On May 28, 2026, the University of California, San Francisco (UCSF) announced that for the first time, researchers…
-
New MRI sensors developed at MIT sensitively detect target molecules in the brain and body.
On May 27, 2026, researchers at Massachusetts Institute of Technology announced that MRI can noninvasively capture detailed images…
-
Scientists solve 200-year-old puzzle of how tobacco plants make nicotine
On May 18, 2026, scientists from the University of York and University of Copenhagen announced they have uncovered…
-
Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
Fujirebio announces CE marking of Lumipulse® G pTau 217 Plasma assay for Alzheimer’s disease
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
